{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:45:11Z","timestamp":1791996311791,"version":"4.4.0"},"reference-count":180,"publisher":"IMR Press","issue":"2","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Elite Ed)"],"abstract":"<jats:p>Adverse intestinal microbiome profiles described as a dysbiotic gut are a complicit etiological operative factor that can progress and maintain inflammatory sequelae in the intestines. The disruption of the gut microbiome that ensues with intestinal dysbiosis is, for example, posited by decreases in the alpha-diversity of the gut microbiome, which is characterized by significant reductions in the abundance of bacterial members from the Bacteroidetes and Firmicutes phyla. Proteobacteria have often been recognized as gut microbial signatures of disease. For example, this happens with observed increases in abundance of the phyla Proteobacteria and Gammaproteobacteria, such as the adherent-invasive Escherichia coli strain, which has been significantly linked with maintaining inflammatory bowel diseases. Research on the administration of probiotics, often identified as gut-functional foods, has demonstrated safety, tolerability, and efficacy issues in treating inflammatory bowel diseases (IBDs). In this narrative review, we explore the efficacy of probiotics in treating IBDs with bacterial strain- and dose-specific characteristics and the association with multi-strain administration.<\/jats:p>","DOI":"10.31083\/j.fbe1602013","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:35:52Z","timestamp":1715315752000},"source":"Crossref","is-referenced-by-count":8,"title":["Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods"],"prefix":"10.31083","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7490-9298","authenticated-orcid":true,"given":"Luis","family":"Vitetta","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia"},{"name":"Research Department, National Institute of Integrative Medicine, Hawthorn, VIC 3122, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Oldfield","sequence":"first","affiliation":[{"name":"Research Department, National Institute of Integrative Medicine, Hawthorn, VIC 3122, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avni","family":"Sali","sequence":"first","affiliation":[{"name":"Research Department, National Institute of Integrative Medicine, Hawthorn, VIC 3122, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Zuo T, Ng SC. The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease. Frontiers in Microbiology. 2018; 9: 2247.","DOI":"10.3389\/fmicb.2018.02247"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Annese V, Annese M. Precision Medicine in Inflammatory Bowel Disease. Diagnostics (Basel, Switzerland). 2023; 13: 2797.","DOI":"10.3390\/diagnostics13172797"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ferretti F, Cannatelli R, Monico MC, Maconi G, Ardizzone S. An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis. Journal of Clinical Medicine. 2022; 11: 2302.","DOI":"10.3390\/jcm11092302"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Feuerstein JD, Cheifetz AS. Crohn Disease: Epidemiology, Diagnosis, and Management. Mayo Clinic Proceedings. 2017; 92: 1088\u20131103.","DOI":"10.1016\/j.mayocp.2017.04.010"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Gu P, Feagins LA. Diet in the Pathogenesis and Management of Crohn\u2019s Disease. Gastroenterology Clinics of North America. 2022; 51: 319\u2013335.","DOI":"10.1016\/j.gtc.2021.12.008"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"So D, Quigley EMM, Whelan K. Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness. Current Opinion in Gastroenterology. 2023; 39: 103\u2013109.","DOI":"10.1097\/MOG.0000000000000902"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, et al. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens (Basel, Switzerland). 2019; 8: 126.","DOI":"10.3390\/pathogens8030126"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Portincasa P, Khalil M, Graziani A, Fr\u00fchbeck G, Baffy G, Garruti G, et al. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? European Journal of Internal Medicine. 2024; 119: 13\u201330.","DOI":"10.1016\/j.ejim.2023.10.002"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, et al. Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients. 2023; 15: 2211.","DOI":"10.3390\/nu15092211"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nature Medicine. 2019; 25: 1822\u20131832.","DOI":"10.1038\/s41591-019-0675-0"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Temple NJ. A rational definition for functional foods: A perspective. Frontiers in Nutrition. 2022; 9: 957516.","DOI":"10.3389\/fnut.2022.957516"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Bai AP, Ouyang Q. Probiotics and inflammatory bowel diseases. Postgraduate Medical Journal. 2006; 82: 376\u2013382.","DOI":"10.1136\/pgmj.2005.040899"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Cortez V, Schultz-Cherry S. The role of goblet cells in viral pathogenesis. The FEBS Journal. 2021; 288: 7060\u20137072.","DOI":"10.1111\/febs.15731"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Vitetta L, Vitetta G, Hall S. Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages. Frontiers in Immunology. 2018; 9: 2240.","DOI":"10.3389\/fimmu.2018.02240"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Cazorla SI, Maldonado-Galdeano C, Weill R, De Paula J, Perdig\u00f3n GDV. Oral Administration of Probiotics Increases Paneth Cells and Intestinal Antimicrobial Activity. Frontiers in Microbiology. 2018; 9: 736.","DOI":"10.3389\/fmicb.2018.00736"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Zhang XF, Guan XX, Tang YJ, Sun JF, Wang XK, Wang WD, et al. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis. European Journal of Nutrition. 2021; 60: 2855\u20132875.","DOI":"10.1007\/s00394-021-02503-5"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Vitetta L, Gorgani NN, Vitetta G, Henson JD. Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus. Biomolecules. 2023; 13: 1307.","DOI":"10.3390\/biom13091307"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Markowiak-Kope\u0107 P, \u015ali\u017cewska K. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome. Nutrients. 2020; 12: 1107.","DOI":"10.3390\/nu12041107"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Li L, Liu T, Gu Y, Wang X, Xie R, Sun Y, et al. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease. Frontiers in Immunology. 2022; 13: 974305.","DOI":"10.3389\/fimmu.2022.974305"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Veledo S, Vendrell J. Gut microbiota-derived succinate: Friend or foe in human metabolic diseases? Reviews in Endocrine & Metabolic Disorders. 2019; 20: 439\u2013447.","DOI":"10.1007\/s11154-019-09513-z"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Mondanelli G, Orecchini E, Volpi C, Panfili E, Belladonna ML, Pallotta MT, et al. Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients. International Journal of Tryptophan Research: IJTR. 2020; 13: 1178646920956646.","DOI":"10.1177\/1178646920956646"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Gasaly N, de Vos P, Hermoso MA. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation. Frontiers in Immunology. 2021; 12: 658354.","DOI":"10.3389\/fimmu.2021.658354"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflammatory Bowel Diseases. 2016; 22: 1137\u20131150.","DOI":"10.1097\/MIB.0000000000000750"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Maccioni L, Fu Y, Horsmans Y, Leclercq I, St\u00e4rkel P, Kunos G, et al. Alcohol-associated bowel disease: new insights into pathogenesis. eGastroenterology. 2023; 1: e100013.","DOI":"10.1136\/egastro-2023-100013"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Chen J, Thomsen M, Vitetta L. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. Journal of Cellular Biochemistry. 2019; 120: 2713\u20132720.","DOI":"10.1002\/jcb.27635"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Chu H, Duan Y, Yang L, Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019; 68: 359\u2013370.","DOI":"10.1136\/gutjnl-2018-316307"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Png CW, Lind\u00e9n SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. The American Journal of Gastroenterology. 2010; 105: 2420\u20132428.","DOI":"10.1038\/ajg.2010.281"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Lu Y, Li X, Liu S, Zhang Y, Zhang D. Toll-like Receptors and Inflammatory Bowel Disease. Frontiers in Immunology. 2018; 9: 72.","DOI":"10.3389\/fimmu.2018.00072"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Elias-Oliveira J, Leite JA, Pereira \u00cdS, Guimar\u00e3es JB, Manso GMDC, Silva JS, et al. NLR and Intestinal Dysbiosis-Associated Inflammatory Illness: Drivers or Dampers? Frontiers in Immunology. 2020; 11: 1810.","DOI":"10.3389\/fimmu.2020.01810"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Le Bourhis L, Benko S, Girardin SE. Nod1 and Nod2 in innate immunity and human inflammatory disorders. Biochemical Society Transactions. 2007; 35: 1479\u20131484.","DOI":"10.1042\/BST0351479"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Akira S, Takeda K. Toll-like receptor signalling. Nature Reviews. Immunology. 2004; 4: 499\u2013511.","DOI":"10.1038\/nri1391"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Zindel J, Kubes P. DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation. Annual Review of Pathology. 2020; 15: 493\u2013518.","DOI":"10.1146\/annurev-pathmechdis-012419-032847"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nature Immunology. 2006; 7: 1250\u20131257.","DOI":"10.1038\/ni1412"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature. 2006; 442: 39\u201344.","DOI":"10.1038\/nature04946"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Mariathasan S, Monack DM. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nature Reviews. Immunology. 2007; 7: 31\u201340.","DOI":"10.1038\/nri1997"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Bohannon JK, Hernandez A, Enkhbaatar P, Adams WL, Sherwood ER. The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants. Shock (Augusta, Ga.). 2013; 40: 451\u2013462.","DOI":"10.1097\/SHK.0000000000000042"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Hernandez A, Patil NK, Stothers CL, Luan L, McBride MA, Owen AM, et al. Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection. Pharmacological Research. 2019; 150: 104502.","DOI":"10.1016\/j.phrs.2019.104502"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Furevi A, St\u00e5hle J, Muheim C, Gkotzis S, Daley DO, Udekwu KI, et al. Elucidation of the O-antigen structure of Escherichia coli O93 and characterization of its biosynthetic genes. Glycobiology. 2023; 33: 289\u2013300.","DOI":"10.1093\/glycob\/cwac069"},{"key":"ref39","unstructured":"Oliveira J, Reygaert WC. Gram-Negative Bacteria. StatPearls (Internet). 2023."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Kutschera A, Schombel U, Schwudke D, Ranf S, Gisch N. Analysis of the Structure and Biosynthesis of the Lipopolysaccharide Core Oligosaccharide of Pseudomonas syringae pv. tomato DC3000. International Journal of Molecular Sciences. 2021; 22: 3250.","DOI":"10.3390\/ijms22063250"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Caruso R, Warner N, Inohara N, N\u00fa\u00f1ez G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 2014; 41: 898\u2013908.","DOI":"10.1016\/j.immuni.2014.12.010"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Ballini A, Charitos IA, Cantore S, Topi S, Bottalico L, Santacroce L. About Functional Foods: The Probiotics and Prebiotics State of Art. Antibiotics (Basel, Switzerland). 2023; 12: 635.","DOI":"10.3390\/antibiotics12040635"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Ma T, Shen X, Shi X, Sakandar HA, Quan K, et al. Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review. Trends in Food Science & Technology. 2023; 138: 178\u2013198.","DOI":"10.1016\/j.tifs.2023.06.013"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Liu Q, Yu Z, Tian F, Zhao J, Zhang H, Zhai Q, et al. Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier. Microbial Cell Factories. 2020; 19: 23.","DOI":"10.1186\/s12934-020-1289-4"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Bermudez-Brito M, Plaza-D\u00edaz J, Mu\u00f1oz-Quezada S, G\u00f3mez-Llorente C, Gil A. Probiotic mechanisms of action. Annals of Nutrition & Metabolism. 2012; 61: 160\u2013174.","DOI":"10.1159\/000342079"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Kong S, Zhang YH, Zhang W. Regulation of Intestinal Epithelial Cells Properties and Functions by Amino Acids. BioMed Research International. 2018; 2018: 2819154.","DOI":"10.1155\/2018\/2819154"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Gou HZ, Zhang YL, Ren LF, Li ZJ, Zhang L. How do intestinal probiotics restore the intestinal barrier? Frontiers in Microbiology. 2022; 13: 929346.","DOI":"10.3389\/fmicb.2022.929346"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Current Gastroenterology Reports. 2010; 12: 319\u2013330.","DOI":"10.1007\/s11894-010-0131-2"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Clevers HC, Bevins CL. Paneth cells: maestros of the small intestinal crypts. Annual Review of Physiology. 2013; 75: 289\u2013311.","DOI":"10.1146\/annurev-physiol-030212-183744"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Fu J, Zong X, Jin M, Min J, Wang F, Wang Y. Mechanisms and regulation of defensins in host defense. Signal Transduction and Targeted Therapy. 2023; 8: 300.","DOI":"10.1038\/s41392-023-01553-x"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Zhang H, Wu J, Li N, Wu R, Chen W. Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective. Biochimica et Biophysica Acta. Reviews on Cancer. 2023; 1878: 188989.","DOI":"10.1016\/j.bbcan.2023.188989"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2010; 298: G807\u2013G819.","DOI":"10.1152\/ajpgi.00243.2009"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Rose EC, Odle J, Blikslager AT, Ziegler AL. Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier Function. International Journal of Molecular Sciences. 2021; 22: 6729.","DOI":"10.3390\/ijms22136729"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nature Reviews. Microbiology. 2011; 9: 356\u2013368.","DOI":"10.1038\/nrmicro2546"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Pimentel-Nunes P, Soares JB, Roncon-Albuquerque R, Jr, Dinis-Ribeiro M, Leite-Moreira AF. Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opinion on Therapeutic Targets. 2010; 14: 347\u2013368.","DOI":"10.1517\/14728221003642027"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Kumar M, Nagpal R, Verma V, Kumar A, Kaur N, Hemalatha R, et al. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutrition Reviews. 2013; 71: 23\u201334.","DOI":"10.1111\/j.1753-4887.2012.00542.x"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Portincasa P, Bonfrate L, Vacca M, De Angelis M, Farella I, Lanza E, et al. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. International Journal of Molecular Sciences. 2022; 23: 1105.","DOI":"10.3390\/ijms23031105"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Donohoe DR, Garge N, Zhang X, Sun W, O\u2019Connell TM, Bunger MK, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metabolism. 2011; 13: 517\u2013526.","DOI":"10.1016\/j.cmet.2011.02.018"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016; 165: 1332\u20131345.","DOI":"10.1016\/j.cell.2016.05.041"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP, et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. The ISME Journal. 2014; 8: 1323\u20131335.","DOI":"10.1038\/ismej.2014.14"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Pessione E. Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows. Frontiers in Cellular and Infection Microbiology. 2012; 2: 86.","DOI":"10.3389\/fcimb.2012.00086"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Sivieri K, Morales MLV, Adorno MAT, Sakamoto IK, Saad SMI, Rossi EA. Lactobacillus acidophilus CRL 1014 improved \u201dgut health\u201d in the SHIME reactor. BMC Gastroenterology. 2013; 13: 100.","DOI":"10.1186\/1471-230X-13-100"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Amaretti A, Bernardi T, Tamburini E, Zanoni S, Lomma M, Matteuzzi D, et al. Kinetics and metabolism of Bifidobacterium adolescentis MB 239 growing on glucose, galactose, lactose, and galactooligosaccharides. Applied and Environmental Microbiology. 2007; 73: 3637\u20133644.","DOI":"10.1128\/AEM.02914-06"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Leonel AJ, Alvarez-Leite JI. Butyrate: implications for intestinal function. Current Opinion in Clinical Nutrition and Metabolic Care. 2012; 15: 474\u2013479.","DOI":"10.1097\/MCO.0b013e32835665fa"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Sun M, Wu W, Liu Z, Cong Y. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. Journal of Gastroenterology. 2017; 52: 1\u20138.","DOI":"10.1007\/s00535-016-1242-9"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Kotlo K, Anbazhagan AN, Priyamvada S, Jayawardena D, Kumar A, Chen Y, et al. The olfactory G protein-coupled receptor (Olfr-78\/OR51E2) modulates the intestinal response to colitis. American Journal of Physiology. Cell Physiology. 2020; 318: C502\u2013C513.","DOI":"10.1152\/ajpcell.00454.2019"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Priyadarshini M, Kotlo KU, Dudeja PK, Layden BT. Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology. Comprehensive Physiology. 2018; 8: 1091\u20131115.","DOI":"10.1002\/cphy.c170050"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Flemming A. Butyrate boosts microbicidal macrophages. Nature Reviews. Immunology. 2019; 19: 135.","DOI":"10.1038\/s41577-019-0132-9"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Burger-van Paassen N, Vincent A, Puiman PJ, van der Sluis M, Bouma J, Boehm G, et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. The Biochemical Journal. 2009; 420: 211\u2013219.","DOI":"10.1042\/BJ20082222"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Zheng L, Kelly CJ, Battista KD, Schaefer R, Lanis JM, Alexeev EE, et al. Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor-Dependent Repression of Claudin-2. Journal of Immunology (Baltimore, Md.: 1950). 2017; 199: 2976\u20132984.","DOI":"10.4049\/jimmunol.1700105"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Schauber J, Svanholm C, Term\u00e9n S, Iffland K, Menzel T, Scheppach W, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut. 2003; 52: 735\u2013741.","DOI":"10.1136\/gut.52.5.735"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Guo W, Zhang Z, Li L, Liang X, Wu Y, Wang X, et al. Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes. Pharmacological Research. 2022; 182: 106355.","DOI":"10.1016\/j.phrs.2022.106355"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Stein RA, Riber L. Epigenetic effects of short-chain fatty acids from the large intestine on host cells. MicroLife. 2023; 4: uqad032.","DOI":"10.1093\/femsml\/uqad032"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Park SY, Kim JS. A short guide to histone deacetylases including recent progress on class II enzymes. Experimental & Molecular Medicine. 2020; 52: 204\u2013212.","DOI":"10.1038\/s12276-020-0382-4"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Bondue P, Delcenserie V. Genome of Bifidobacteria and Carbohydrate Metabolism. Korean Journal for Food Science of Animal Resources. 2015; 35: 1\u20139.","DOI":"10.5851\/kosfa.2015.35.1.1"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"De Vuyst L, Leroy F. Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. International Journal of Food Microbiology. 2011; 149: 73\u201380.","DOI":"10.1016\/j.ijfoodmicro.2011.03.003"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Horiuchi H, Kamikado K, Aoki R, Suganuma N, Nishijima T, Nakatani A, et al. Bifidobacterium animalis subsp. lactis GCL2505 modulates host energy metabolism via the short-chain fatty acid receptor GPR43. Scientific Reports. 2020; 10: 4158.","DOI":"10.1038\/s41598-020-60984-6"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Berni Canani R, Di Costanzo M, Leone L. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clinical Epigenetics. 2012; 4: 4.","DOI":"10.1186\/PREACCEPT-1764710053667755"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Mocking RJT, Assies J, Ruh\u00e9 HG, Schene AH. Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders. Journal of Inherited Metabolic Disease. 2018; 41: 597\u2013611.","DOI":"10.1007\/s10545-018-0158-3"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Carlezon WA, Jr, Mague SD, Parow AM, Stoll AL, Cohen BM, Renshaw PF. Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biological Psychiatry. 2005; 57: 343\u2013350.","DOI":"10.1016\/j.biopsych.2004.11.038"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Davie JR. Inhibition of histone deacetylase activity by butyrate. The Journal of Nutrition. 2003; 133: 2485S\u20132493S.","DOI":"10.1093\/jn\/133.7.2485S"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science (New York, N.Y.). 2013; 339: 211\u2013214.","DOI":"10.1126\/science.1227166"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cellular and Molecular Life Sciences: CMLS. 2019; 76: 473\u2013493.","DOI":"10.1007\/s00018-018-2943-4"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019; 7: 14.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011; 473: 174\u2013180.","DOI":"10.1038\/nature09944"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Li J, Butcher J, Mack D, Stintzi A. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflammatory Bowel Diseases. 2015; 21: 139\u2013153.","DOI":"10.1097\/MIB.0000000000000215"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Clayton EM, Rea MC, Shanahan F, Quigley EMM, Kiely B, Hill C, et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. The American Journal of Gastroenterology. 2009; 104: 1162\u20131169.","DOI":"10.1038\/ajg.2009.4"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Bien J, Palagani V, Bozko P. The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? Therapeutic Advances in Gastroenterology. 2013; 6: 53\u201368.","DOI":"10.1177\/1756283X12454590"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Mondot S, Kang S, Furet JP, Aguirre de Carcer D, McSweeney C, Morrison M, et al. Highlighting new phylogenetic specificities of Crohn\u2019s disease microbiota. Inflammatory Bowel Diseases. 2011; 17: 185\u2013192.","DOI":"10.1002\/ibd.21436"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Shanahan F, Bernstein CN. The evolving epidemiology of inflammatory bowel disease. Current Opinion in Gastroenterology. 2009; 25: 301\u2013305.","DOI":"10.1097\/MOG.0b013e32832b12ef"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets. International Journal of Molecular Sciences. 2022; 23: 3464.","DOI":"10.3390\/ijms23073464"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Belzer C, Chia LW, Aalvink S, Chamlagain B, Piironen V, Knol J, et al. Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B_\u206212 Production by Intestinal Symbionts. mBio. 2017; 8: e00770-17.","DOI":"10.1128\/mBio.00770-17"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Azad MAK, Sarker M, Wan D. Immunomodulatory Effects of Probiotics on Cytokine Profiles. BioMed Research International. 2018; 2018: 8063647.","DOI":"10.1155\/2018\/8063647"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Jakubczyk D, Leszczy\u0144ska K, G\u00f3rska S. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review. Nutrients. 2020; 12: 1973.","DOI":"10.3390\/nu12071973"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Limketkai BN, Akobeng AK, Gordon M, Adepoju AA. Probiotics for induction of remission in Crohn\u2019s disease. The Cochrane Database of Systematic Reviews. 2020; 7: CD006634.","DOI":"10.1002\/14651858.CD006634.pub3"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Butorac K, Novak J, Bani\u0107 M, Lebo\u0161 Pavunc A, \u010culjak N, Or\u0161oli\u0107 N, et al. Modulation of the Gut Microbiota by the Plantaricin-Producing Lactiplantibacillus plantarum D13, Analysed in the DSS-Induced Colitis Mouse Model. International Journal of Molecular Sciences. 2023; 24: 15322.","DOI":"10.3390\/ijms242015322"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Alimentary Pharmacology & Therapeutics. 2004; 20: 1133\u20131141.","DOI":"10.1111\/j.1365-2036.2004.02268.x"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Hegazy SK, El-Bedewy MM. Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World Journal of Gastroenterology. 2010; 16: 4145\u20134151.","DOI":"10.3748\/wjg.v16.i33.4145"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Groeger D, O\u2019Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes. 2013; 4: 325\u2013339.","DOI":"10.4161\/gmic.25487"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Ishikawa H, Matsumoto S, Ohashi Y, Imaoka A, Setoyama H, Umesaki Y, et al. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Digestion. 2011; 84: 128\u2013133.","DOI":"10.1159\/000322977"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Matsuoka K, Uemura Y, Kanai T, Kunisaki R, Suzuki Y, Yokoyama K, et al. Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis. Digestive Diseases and Sciences. 2018; 63: 1910\u20131919.","DOI":"10.1007\/s10620-018-4946-2"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"Wildt S, Nordgaard I, Hansen U, Brockmann E, Rumessen JJ. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis. Journal of Crohn\u2019s & Colitis. 2011; 5: 115\u2013121.","DOI":"10.1016\/j.crohns.2010.11.004"},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"Tamaki H, Nakase H, Inoue S, Kawanami C, Itani T, Ohana M, et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial. Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society. 2016; 28: 67\u201374.","DOI":"10.1111\/den.12553"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Palumbo VD, Romeo M, Marino Gammazza A, Carini F, Damiani P, Damiano G, et al. The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 2016; 160: 372\u2013377.","DOI":"10.5507\/bp.2016.044"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"Sood A, Midha V, Makharia GK, Ahuja V, Singal D, Goswami P, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clinical Gastroenterology and Hepatology. 2009; 7: 1202\u20131209,1209.e1.","DOI":"10.1016\/j.cgh.2009.07.016"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. The American Journal of Gastroenterology. 2010; 105: 2218\u20132227.","DOI":"10.1038\/ajg.2010.218"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Huynh HQ, deBruyn J, Guan L, Diaz H, Li M, Girgis S, et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflammatory Bowel Diseases. 2009; 15: 760\u2013768.","DOI":"10.1002\/ibd.20816"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"Oliva S, Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G, et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Alimentary Pharmacology & Therapeutics. 2012; 35: 327\u2013334.","DOI":"10.1111\/j.1365-2036.2011.04939.x"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Petersen AM, Mirsepasi H, Halkj\u00e6r SI, Mortensen EM, Nordgaard-Lassen I, Krogfelt KA. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial. Journal of Crohn\u2019s & Colitis. 2014; 8: 1498\u20131505.","DOI":"10.1016\/j.crohns.2014.06.001"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"Park SK, Kang SB, Kim S, Kim TO, Cha JM, Im JP, et al. Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis. The Korean Journal of Internal Medicine. 2022; 37: 949\u2013957.","DOI":"10.3904\/kjim.2021.458"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"Matthes H, Krummenerl T, Giensch M, Wolff C, Schulze J. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complementary and Alternative Medicine. 2010; 10: 13.","DOI":"10.1186\/1472-6882-10-13"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet (London, England). 2017; 389: 1218\u20131228.","DOI":"10.1016\/S0140-6736(17)30182-4"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"Wei Y, Gong J, Zhu W, Tian H, Ding C, Gu L, et al. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora. BMC Microbiology. 2016; 16: 255.","DOI":"10.1186\/s12866-016-0869-2"},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"Rossen NG, Fuentes S, van der Spek MJ, Tijssen JG, Hartman JHA, Duflou A, et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology. 2015; 149: 110\u2013118.e4.","DOI":"10.1053\/j.gastro.2015.03.045"},{"key":"ref115","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015; 149: 102\u2013109.e6.","DOI":"10.1053\/j.gastro.2015.04.001"},{"key":"ref116","doi-asserted-by":"crossref","unstructured":"Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, et al. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial. JAMA. 2019; 321: 156\u2013164.","DOI":"10.1001\/jama.2018.20046"},{"key":"ref117","doi-asserted-by":"crossref","unstructured":"Herfarth H, Barnes EL, Long MD, Isaacs KL, Leith T, Silverstein M, et al. Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment. Inflammatory Intestinal Diseases. 2019; 4: 1\u20136.","DOI":"10.1159\/000497042"},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"Sood A, Mahajan R, Singh A, Midha V, Mehta V, Narang V, et al. Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study. Journal of Crohn\u2019s & Colitis. 2019; 13: 1311\u20131317.","DOI":"10.1093\/ecco-jcc\/jjz060"},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"Ianiro G, Bibb\u00f2 S, Porcari S, Settanni CR, Giamb\u00f2 F, Curta AR, et al. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center. Gut Microbes. 2021; 13: 1994834.","DOI":"10.1080\/19490976.2021.1994834"},{"key":"ref120","doi-asserted-by":"crossref","unstructured":"Crothers JW, Chu ND, Nguyen LTT, Phillips M, Collins C, Fortner K, et al. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. BMC Gastroenterology. 2021; 21: 281.","DOI":"10.1186\/s12876-021-01856-9"},{"key":"ref121","doi-asserted-by":"crossref","unstructured":"Chen M, Liu XL, Zhang YJ, Nie YZ, Wu KC, Shi YQ. Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis. Journal of Digestive Diseases. 2020; 21: 621\u2013628.","DOI":"10.1111\/1751-2980.12938"},{"key":"ref122","doi-asserted-by":"crossref","unstructured":"Jacob V, Crawford C, Cohen-Mekelburg S, Viladomiu M, Putzel GG, Schneider Y, et al. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis. Inflammatory Bowel Diseases. 2017; 23: 903\u2013911.","DOI":"10.1097\/MIB.0000000000001132"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama Torres H, Guerra Pinto A, Carolina Carneiro Aguirre A, Paiva Martins F, et al. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn\u2019s disease in remission. Scandinavian Journal of Gastroenterology. 2008; 43: 842\u2013848.","DOI":"10.1080\/00365520801943354"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"Bjarnason I, Sission G, Hayee B. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn\u2019s disease. Inflammopharmacology. 2019; 27: 465\u2013473.","DOI":"10.1007\/s10787-019-00595-4"},{"key":"ref125","doi-asserted-by":"crossref","unstructured":"Steed H, Macfarlane GT, Blackett KL, Bahrami B, Reynolds N, Walsh SV, et al. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn\u2019s disease. Alimentary Pharmacology & Therapeutics. 2010; 32: 872\u2013883.","DOI":"10.1111\/j.1365-2036.2010.04417.x"},{"key":"ref126","doi-asserted-by":"crossref","unstructured":"Schultz M, Timmer A, Herfarth HH, Sartor RB, Vanderhoof JA, Rath HC. Lactobacillus GG in inducing and maintaining remission of Crohn\u2019s disease. BMC Gastroenterology. 2004; 4: 5.","DOI":"10.1186\/1471-230X-4-5"},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"Bourreille A, Cadiot G, Le Dreau G, Laharie D, Beaugerie L, Dupas JL, et al. Saccharomyces boulardii does not prevent relapse of Crohn\u2019s disease. Clinical Gastroenterology and Hepatology. 2013; 11: 982\u2013987.","DOI":"10.1016\/j.cgh.2013.02.021"},{"key":"ref128","doi-asserted-by":"crossref","unstructured":"Yang Z, Bu C, Yuan W, Shen Z, Quan Y, Wu S, et al. Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn\u2019s Disease. Digestive Diseases and Sciences. 2020; 65: 150\u2013157.","DOI":"10.1007\/s10620-019-05751-y"},{"key":"ref129","doi-asserted-by":"crossref","unstructured":"Sokol H, Landman C, Seksik P, Berard L, Montil M, Nion-Larmurier I, et al. Fecal microbiota transplantation to maintain remission in Crohn\u2019s disease: a pilot randomized controlled study. Microbiome. 2020; 8: 12.","DOI":"10.1186\/s40168-020-0792-5"},{"key":"ref130","doi-asserted-by":"crossref","unstructured":"Shadnoush M, Hosseini RS, Khalilnezhad A, Navai L, Goudarzi H, Vaezjalali M. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi. 2015; 65: 215\u2013221.","DOI":"10.4166\/kjg.2015.65.4.215"},{"key":"ref131","doi-asserted-by":"crossref","unstructured":"Ballini A, Santacroce L, Cantore S, Bottalico L, Dipalma G, Topi S, et al. Probiotics Efficacy on Oxidative Stress Values in Inflammatory Bowel Disease: A Randomized Double-Blinded Placebo-Controlled Pilot Study. Endocrine, Metabolic & Immune Disorders Drug Targets. 2019; 19: 373\u2013381.","DOI":"10.2174\/1871530319666181221150352"},{"key":"ref132","doi-asserted-by":"crossref","unstructured":"Y\u0131lmaz \u0130, Dolar ME, \u00d6zp\u0131nar H. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial. The Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology. 2019; 30: 242\u2013253.","DOI":"10.5152\/tjg.2018.18227"},{"key":"ref133","doi-asserted-by":"crossref","unstructured":"Fan H, Du J, Liu X, Zheng WW, Zhuang ZH, Wang CD, et al. Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease. The Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology. 2019; 30: 680\u2013685.","DOI":"10.5152\/tjg.2019.18426"},{"key":"ref134","doi-asserted-by":"crossref","unstructured":"Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clinical and Experimental Immunology. 2007; 149: 470\u2013479.","DOI":"10.1111\/j.1365-2249.2007.03434.x"},{"key":"ref135","doi-asserted-by":"crossref","unstructured":"Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease. Clinical Gastroenterology and Hepatology. 2006; 4: 754\u2013759.","DOI":"10.1016\/j.cgh.2006.03.028"},{"key":"ref136","doi-asserted-by":"crossref","unstructured":"Caldeira LDF, Borba HH, Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis. PLoS ONE. 2020; 15: e0238910.","DOI":"10.1371\/journal.pone.0238910"},{"key":"ref137","doi-asserted-by":"crossref","unstructured":"Silanikove N, Leitner G, Merin U. The Interrelationships between Lactose Intolerance and the Modern Dairy Industry: Global Perspectives in Evolutional and Historical Backgrounds. Nutrients. 2015; 7: 7312\u20137331.","DOI":"10.3390\/nu7095340"},{"key":"ref138","doi-asserted-by":"crossref","unstructured":"Rozenberg S, Body JJ, Bruy\u00e8re O, Bergmann P, Brandi ML, Cooper C, et al. Effects of Dairy Products Consumption on Health: Benefits and Beliefs\u2013A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. Calcified Tissue International. 2016; 98: 1\u201317.","DOI":"10.1007\/s00223-015-0062-x"},{"key":"ref139","doi-asserted-by":"crossref","unstructured":"Storhaug CL, Fosse SK, Fadnes LT. Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. The Lancet. Gastroenterology & Hepatology. 2017; 2: 738\u2013746.","DOI":"10.1016\/S2468-1253(17)30154-1"},{"key":"ref140","doi-asserted-by":"crossref","unstructured":"Li A, Zheng J, Han X, Yang S, Cheng S, Zhao J, et al. Advances in Low-Lactose\/Lactose-Free Dairy Products and Their Production. Foods (Basel, Switzerland). 2023; 12: 2553.","DOI":"10.3390\/foods12132553"},{"key":"ref141","doi-asserted-by":"crossref","unstructured":"Sibley E. Genetic variation and lactose intolerance: detection methods and clinical implications. American Journal of Pharmacogenomics: Genomics-related Research in Drug Development and Clinical Practice. 2004; 4: 239\u2013245.","DOI":"10.2165\/00129785-200404040-00003"},{"key":"ref142","doi-asserted-by":"crossref","unstructured":"Leis R, de Castro MJ, de Lamas C, Pic\u00e1ns R, Couce ML. Effects of Prebiotic and Probiotic Supplementation on Lactase Deficiency and Lactose Intolerance: A Systematic Review of Controlled Trials. Nutrients. 2020; 12: 1487.","DOI":"10.3390\/nu12051487"},{"key":"ref143","doi-asserted-by":"crossref","unstructured":"Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek. 2002; 82: 279\u2013289.","DOI":"10.1007\/978-94-017-2029-8_18"},{"key":"ref144","doi-asserted-by":"crossref","unstructured":"Marteau P, Flourie B, Pochart P, Chastang C, Desjeux JF, Rambaud JC. Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: an in vivo study in lactase-deficient humans. The British Journal of Nutrition. 1990; 64: 71\u201379.","DOI":"10.1079\/BJN19900010"},{"key":"ref145","doi-asserted-by":"crossref","unstructured":"Marteau P, Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Practice & Research. Clinical Gastroenterology. 2003; 17: 725\u2013740.","DOI":"10.1016\/S1521-6918(03)00055-6"},{"key":"ref146","unstructured":"He T, Priebe MG, Zhong Y, Huang C, Harmsen HJM, Raangs GC, et al. Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. Journal of Applied Microbiology. 2008; 104: 595\u2013604."},{"key":"ref147","doi-asserted-by":"crossref","unstructured":"Dhama K, Latheef SK, Munjal AK, Khandia R, Samad HA, Iqbal HMN, et al. Probiotics in Curing Allergic and Inflammatory Conditions - Research Progress and Futuristic Vision. Recent Patents on Inflammation & Allergy Drug Discovery. 2017; 10: 105\u2013118.","DOI":"10.2174\/1872213X10666161226162229"},{"key":"ref148","doi-asserted-by":"crossref","unstructured":"Corr SC, Hill C, Gahan CGM. Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Advances in Food and Nutrition Research. 2009; 56: 1\u201315.","DOI":"10.1016\/S1043-4526(08)00601-3"},{"key":"ref149","doi-asserted-by":"crossref","unstructured":"Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, et al. Intestinal permeability\u2013a new target for disease prevention and therapy. BMC Gastroenterology. 2014; 14: 189.","DOI":"10.1186\/s12876-014-0189-7"},{"key":"ref150","doi-asserted-by":"crossref","unstructured":"Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014; 157: 121\u2013141.","DOI":"10.1016\/j.cell.2014.03.011"},{"key":"ref151","doi-asserted-by":"crossref","unstructured":"Kwak HaeSoo KH, Lee WonJae LW, Lee MeeRyung LM. Revisiting lactose as an enhancer of calcium absorption. International Dairy Journal. 2012; 22: 147\u2013151.","DOI":"10.1016\/j.idairyj.2011.09.002"},{"key":"ref152","doi-asserted-by":"crossref","unstructured":"Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells. 2023; 12: 184.","DOI":"10.3390\/cells12010184"},{"key":"ref153","doi-asserted-by":"crossref","unstructured":"Bintsis T, Papademas P. The evolution of fermented milks, from artisanal to industrial products: A critical review. Fermentation. 2022; 8: 679.","DOI":"10.3390\/fermentation8120679"},{"key":"ref154","doi-asserted-by":"crossref","unstructured":"Guo X, Long R, Kreuzer M, Ding L, Shang Z, Zhang Y, et al. Importance of functional ingredients in yak milk-derived food on health of Tibetan nomads living under high-altitude stress: a review. Critical Reviews in Food Science and Nutrition. 2014; 54: 292\u2013302.","DOI":"10.1080\/10408398.2011.584134"},{"key":"ref155","unstructured":"Metchnikoff E. The prolongation of life: optimistic studies. The Knickerbocker Press: New York, London. The Knickerbocker Press. 2016."},{"key":"ref156","unstructured":"Tissier H. Treatment of intestinal infections using bacterial flora of the intestine. Crit Rev Soc Biol. 1906; 60: 359\u2013361. (In French)"},{"key":"ref157","doi-asserted-by":"crossref","unstructured":"Rettger LF, Cheplin HA. Bacillus acidophilus and its therapeutic application. Archives of Internal Medicine. 1922; 29: 357\u2013367.","DOI":"10.1001\/archinte.1922.00110030082005"},{"key":"ref158","doi-asserted-by":"crossref","unstructured":"Kopeloff N, Blackman N, McGinn B. The incidence of Lactobacillus acidophilus in adults. The Journal of Infectious Diseases. 1932; 426\u2013429.","DOI":"10.1093\/infdis\/50.5-6.426"},{"key":"ref159","doi-asserted-by":"crossref","unstructured":"Nitzan O, Elias M, Peretz A, Saliba W. Role of antibiotics for treatment of inflammatory bowel disease. World Journal of Gastroenterology. 2016; 22: 1078\u20131087.","DOI":"10.3748\/wjg.v22.i3.1078"},{"key":"ref160","doi-asserted-by":"crossref","unstructured":"Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut. 2020; 69: 1510\u20131519.","DOI":"10.1136\/gutjnl-2019-320204"},{"key":"ref161","doi-asserted-by":"crossref","unstructured":"Cai Z, Wang S, Li J. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Frontiers in Medicine. 2021; 8: 765474.","DOI":"10.3389\/fmed.2021.765474"},{"key":"ref162","doi-asserted-by":"crossref","unstructured":"Gordon M, Sinopoulou V, Grafton-Clarke C, Akobeng AK. Antibiotics for the induction and maintenance of remission in ulcerative colitis. The Cochrane Database of Systematic Reviews. 2022; 5: CD013743.","DOI":"10.1002\/14651858.CD013743.pub2"},{"key":"ref163","doi-asserted-by":"crossref","unstructured":"Lorentz A, M\u00fcller L. Probiotics in the Treatment of Inflammatory Bowel Disease in Adulthood: A Systematic Review. Journal of Gastrointestinal and Liver Diseases: JGLD. 2022; 31: 74\u201384.","DOI":"10.15403\/jgld-3936"},{"key":"ref164","doi-asserted-by":"crossref","unstructured":"McFarland LV. From yaks to yogurt: the history, development, and current use of probiotics. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2015; 60: S85\u2013S90.","DOI":"10.1093\/cid\/civ054"},{"key":"ref165","doi-asserted-by":"crossref","unstructured":"Emile SH, Horesh N, Freund MR, Garoufalia Z, Gefen R, Khan SM, et al. A Systematic Review and Meta-analysis of Randomized Clinical Trials on the Prevention and Treatment of Pouchitis after Ileoanal Pouch Anastomosis. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract. 2023; 27: 2650\u20132660.","DOI":"10.1007\/s11605-023-05841-3"},{"key":"ref166","doi-asserted-by":"crossref","unstructured":"Wang S, Yin P, Yu L, Tian F, Chen W, Zhai Q. Effects of Early Diet on the Prevalence of Allergic Disease in Children: A Systematic Review and Meta-Analysis. Advances in Nutrition (Bethesda, Md.). 2024; 15: 100128.","DOI":"10.1016\/j.advnut.2023.10.001"},{"key":"ref167","doi-asserted-by":"crossref","unstructured":"Li H, Zhang L, Yang F, Zhao R, Li X, Li H. Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review. Frontiers in Immunology. 2023; 14: 1218386.","DOI":"10.3389\/fimmu.2023.1218386"},{"key":"ref168","doi-asserted-by":"crossref","unstructured":"Kow CS, Ramachandram DS, Hasan SS. The effect of probiotics on the risk of mortality in patients with COVID-19: systematic review and meta-analysis of randomized trials. Inflammopharmacology. 2023; 31: 3327\u20133332.","DOI":"10.1007\/s10787-023-01358-y"},{"key":"ref169","unstructured":"Su D, Liu Y, Zhang L, Zhao S, Wang Y, Bian R, et al. Potential Value of Probiotics on Lipid Profiles in Hyperlipidemia and Healthy Participants: Systematic Review and Meta-Analysis. Alternative Therapies in Health and Medicine. 2023. (online ahead of print)"},{"key":"ref170","doi-asserted-by":"crossref","unstructured":"Kou J, Kang H, Hu L, Wang D, Wang S, Wang Q, et al. Evaluation of improvement of cognitive impairment in older adults with probiotic supplementation: A systematic review and meta-analysis. Geriatric Nursing (New York, N.Y.). 2023; 54: 155\u2013162.","DOI":"10.1016\/j.gerinurse.2023.09.009"},{"key":"ref171","doi-asserted-by":"crossref","unstructured":"Wang Y, Florez ID, Morgan RL, Foroutan F, Chang Y, Crandon HN, et al. Probiotics, Prebiotics, Lactoferrin, and Combination Products for Prevention of Mortality and Morbidity in Preterm Infants: A Systematic Review and Network Meta-Analysis. JAMA Pediatrics. 2023; 177: 1158\u20131167.","DOI":"10.1001\/jamapediatrics.2023.3849"},{"key":"ref172","doi-asserted-by":"crossref","unstructured":"NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P, Wang L, et al. The NIH Human Microbiome Project. Genome Research. 2009; 19: 2317\u20132323.","DOI":"10.1101\/gr.096651.109"},{"key":"ref173","doi-asserted-by":"crossref","unstructured":"Vitetta L, Bambling M, Strodl E. Probiotics and Commensal Bacteria Metabolites Trigger Epigenetic Changes in the Gut and Influence Beneficial Mood Dispositions. Microorganisms. 2023; 11: 1334.","DOI":"10.3390\/microorganisms11051334"},{"key":"ref174","doi-asserted-by":"crossref","unstructured":"Zhou J, Li M, Chen Q, Li X, Chen L, Dong Z, et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nature Communications. 2022; 13: 3432.","DOI":"10.1038\/s41467-022-31171-0"},{"key":"ref175","doi-asserted-by":"crossref","unstructured":"Linnane AW, Kios M, Vitetta L. Healthy aging: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: the essential roles of superoxide anion and hydrogen peroxide. Biogerontology. 2007; 8: 445\u2013467.","DOI":"10.1007\/s10522-007-9096-4"},{"key":"ref176","doi-asserted-by":"crossref","unstructured":"Nantapong N, Murata R, Trakulnaleamsai S, Kataoka N, Yakushi T, Matsushita K. The effect of reactive oxygen species (ROS) and ROS-scavenging enzymes, superoxide dismutase and catalase, on the thermotolerant ability of Corynebacterium glutamicum. Applied Microbiology and Biotechnology. 2019; 103: 5355\u20135366.","DOI":"10.1007\/s00253-019-09848-2"},{"key":"ref177","doi-asserted-by":"crossref","unstructured":"Linnane AW, Kios M, Vitetta L. The essential requirement for superoxide radical and nitric oxide formation for normal physiological function and healthy aging. Mitochondrion. 2007; 7: 1\u20135.","DOI":"10.1016\/j.mito.2006.11.009"},{"key":"ref178","doi-asserted-by":"crossref","unstructured":"Praveschotinunt P, Duraj-Thatte AM, Gelfat I, Bahl F, Chou DB, Joshi NS. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nature Communications. 2019; 10: 5580.","DOI":"10.1038\/s41467-019-13336-6"},{"key":"ref179","doi-asserted-by":"crossref","unstructured":"Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews. Gastroenterology & Hepatology. 2021; 18: 649\u2013667.","DOI":"10.1038\/s41575-021-00440-6"},{"key":"ref180","doi-asserted-by":"crossref","unstructured":"Martyniak A, Medy\u0144ska-Prz\u0119czek A, W\u0119drychowicz A, Skocze\u0144 S, Tomasik PJ. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD. Biomolecules. 2021; 11: 1903.","DOI":"10.3390\/biom11121903"}],"container-title":["Frontiers in Bioscience-Elite"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBE\/16\/2\/10.31083\/j.fbe1602013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T06:04:32Z","timestamp":1732687472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBE\/16\/2\/10.31083\/j.fbe1602013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":180,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["S1945-0494(24)00137-1"],"URL":"https:\/\/doi.org\/10.31083\/j.fbe1602013","relation":{},"ISSN":["1945-0494","1945-0508"],"issn-type":[{"value":"1945-0494","type":"print"},{"value":"1945-0508","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"article-number":"13"}}